Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NJ › Flemington › NPI 1922095116
Hospital

Hunterdon Medical Center

Hunterdon Medical Center was paid $40.35M by Medicaid between Jan 2018 and Nov 2024, across 245 billing codes. Its largest line is H0035, Mental health partial hospitalization, treatment, less than 24 hours — 16% of everything it billed.

33Billing provider infoHUNTERDON MEDICAL CENTER
FLEMINGTON, NJ 08822
33aNPI1922095116assigned 10/03/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$40.35M
24GClaims695,097
24DCodes billed245
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers

Next to other General Acute Care Hospital providers in New Jersey

Rank by total paid#39 of 93
Median peer was paid$30.60M
This provider vs. median1.3×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201879,896$5.88M
201984,490$6.06M
202080,293$5.35M
2021102,068$5.83M
2022122,891$5.97M
2023128,643$6.16M
2024incomplete96,816$5.10M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
H0035 Mental health partial hospitalization, treatment, less than 24 hours 16% 65,710 7,500 $6.40M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 9.2% 12,496 11,362 $3.73M
90832 Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient 8.2% 27,865 15,979 $3.30M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 7.6% 11,462 10,746 $3.07M
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 4.6% 2,189 2,127 $1.85M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 4.5% 6,326 5,669 $1.83M
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 4.0% 1,149 1,104 $1.60M
A0427 Emergency ambulance ride, advanced life supportAmbulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) 3.7% 6,991 6,417 $1.49M
S9480 Intensive outpatient psychiatric services, per diem 3.5% 3,837 2,336 $1.43M
74177 Computed tomography, abdomen and pelvis; with contrast material 3.0% 2,415 2,323 $1.23M
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 2.9% 40,163 11,724 $1.15M
G0378 Hospital observation service, per hour 2.6% 2,812 2,311 $1.05M
233 more codes
90853 Group psychotherapy (other than of a multiple-family group) 1.4% 25,754 $575K
45380 Colonoscopy, flexible; with biopsy, single or multiple 1.3% 362 $540K
90791 Psychiatric diagnostic evaluation 1.3% 4,718 $533K
OP272 1.3% 11,537 $531K
93017 1.1% 842 $436K
97530 Therapeutic activities, direct patient contact, each 15 minutes 1.1% 9,705 $432K
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) <1% 322 $403K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 9,938 $384K
OP270 <1% 10,023 $379K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 2,126 $346K
93970 <1% 1,069 $339K
70450 Computed tomography, head or brain; without contrast material <1% 3,221 $320K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 2,620 $311K
77067 Screening mammography, bilateral, including computer-aided detection <1% 3,034 $295K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 1,167 $281K
A0425 Ground mileage, per statute mile <1% 7,586 $248K
93971 <1% 1,036 $229K
97803 <1% 2,877 $209K
71046 Radiologic examination, chest; 2 views <1% 4,535 $209K
97161 <1% 4,064 $195K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 4,465 $188K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 11,840 $177K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 3,963 $176K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 617 $170K
96361 Intravenous infusion, hydration; each additional hour <1% 4,304 $148K
80048 Basic metabolic panel (calcium, ionized) <1% 20,912 $147K
C1776 Joint device (implantable) <1% 28 $139K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 25,181 $138K
71045 Radiologic examination, chest; single view <1% 6,003 $138K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 127 $125K
76536 <1% 663 $121K
76642 <1% 1,248 $112K
OP710 <1% 2,917 $111K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 5,938 $106K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 304 $101K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 1,965 $99K
97802 <1% 657 $97K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 3,565 $84K
96375 Therapeutic injection; each additional sequential IV push <1% 3,110 $82K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 1,618 $80K
OP250 <1% 31,646 $79K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 48 $79K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 3,254 $78K
90834 Psychotherapy session, about 45 minutes <1% 5,006 $77K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 737 $76K
71250 <1% 240 $76K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 4,471 $68K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 1,310 $62K
80076 <1% 11,270 $60K
76830 Ultrasound, transvaginal <1% 594 $56K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 3,053 $54K
OP258 <1% 9,254 $52K
87631 <1% 1,381 $51K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 506 $48K
T2034 Crisis intervention, waiver; per diem <1% 64 $48K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 3,523 $47K
81001 <1% 10,267 $45K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 2,402 $44K
77066 Tomosynthesis, mammo <1% 401 $44K
77063 Screening digital breast tomosynthesis, bilateral <1% 2,169 $43K
80053 Comprehensive metabolic panel <1% 9,042 $43K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 983 $42K
83735 <1% 9,384 $39K
77065 Tomosynthesis, mammo <1% 426 $39K
OP259 <1% 26,771 $38K
76770 <1% 276 $38K
83605 <1% 3,181 $34K
85610 <1% 7,060 $32K
85730 <1% 6,031 $29K
80320 <1% 3,195 $29K
87086 Culture, bacterial; quantitative colony count, urine <1% 4,937 $29K
84484 <1% 5,675 $29K
84443 Thyroid stimulating hormone (TSH) <1% 5,994 $27K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 1,103 $27K
J3490 Unclassified drugs <1% 6,106 $26K
87040 <1% 2,269 $26K
82948 <1% 5,670 $25K
83690 <1% 5,914 $25K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 6,272 $22K
36415 Collection of venous blood by venipuncture <1% 11,395 $21K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 3,428 $20K
94060 <1% 39 $20K
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 2,152 $20K
90839 <1% 794 $19K
74018 <1% 395 $18K
J2704 Injection, propofol, 10 mg <1% 4,882 $18K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 15 $18K
77080 <1% 256 $18K
73630 <1% 324 $18K
J2060 Injection, lorazepam, 2 mg <1% 1,236 $16K
73562 <1% 283 $16K
J7120 Ringers lactate infusion, up to 1000 cc <1% 2,204 $15K
71275 Computed tomographic angiography, chest, with contrast material <1% 82 $15K
97162 <1% 368 $15K
94729 <1% 71 $14K
72110 <1% 121 $14K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 3,258 $13K
85027 <1% 5,003 $13K
J0690 Injection, cefazolin sodium, 500 mg <1% 1,908 $13K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 1,844 $12K
82550 <1% 2,810 $12K
94727 <1% 71 $11K
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg <1% 1,309 $11K
73610 <1% 243 $11K
84439 <1% 3,052 $11K
G0108 Diabetes outpatient self-management training services, individual, per 30 minutes <1% 56 $10K
86900 <1% 1,623 $10K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 314 $10K
00731 <1% 330 $10K
59025 Fetal non-stress test <1% 33 $10K
83880 <1% 1,789 $9K
97597 <1% 103 $8K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 386 $8K
S9484 Crisis intervention mental health services, per hour <1% 36 $8K
73030 <1% 164 $8K
86850 <1% 1,568 $7K
93041 <1% 763 $7K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 886 $7K
84702 <1% 1,662 $7K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 4,074 $7K
76942 <1% 193 $7K
81025 <1% 3,769 $6K
J1170 Injection, hydromorphone, up to 4 mg <1% 2,243 $6K
J7030 Infusion, normal saline solution , 1000 cc <1% 1,121 $6K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 22 $6K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 3,279 $6K
73130 <1% 137 $6K
90715 <1% 315 $5K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 684 $5K
97116 <1% 398 $5K
72125 Computed tomography, cervical spine; without contrast material <1% 49 $5K
73110 <1% 76 $5K
96376 <1% 388 $5K
80061 Lipid panel <1% 3,223 $4K
90840 <1% 107 $4K
94375 <1% 27 $4K
85379 <1% 1,647 $4K
87186 <1% 859 $4K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 488 $4K
00812 <1% 196 $4K
83036 Hemoglobin; glycosylated (A1C) <1% 3,976 $4K
97165 <1% 166 $4K
J2270 Injection, morphine sulfate, up to 10 mg <1% 1,709 $4K
64447 <1% 14 $4K
99214 Doctor's office visit, returning patient (more involved) <1% 221 $4K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 262 $3K
92587 <1% 26 $3K
J1644 Injection, heparin sodium, per 1000 units <1% 1,127 $3K
81003 <1% 695 $3K
J3535 Drug administered through a metered dose inhaler <1% 154 $2K
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 639 $2K
86618 <1% 410 $2K
73590 <1% 13 $2K
84100 <1% 1,043 $1K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 44 $1K
92588 <1% 12 $1K
86317 <1% 138 $1K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 889 $1K
71271 <1% 13 $1K
00811 <1% 31 $1K
82150 <1% 265 $1K
00813 <1% 41 $867.00
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose <1% 120 $809.30
95800 <1% 28 $792.36
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 605 $787.52
C9113 Injection, pantoprazole sodium, per vial <1% 387 $778.79
84703 <1% 604 $763.76
73140 <1% 13 $705.85
J0689 Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg <1% 281 $670.81
A4649 Surgical supply; miscellaneous <1% 34 $613.43
86140 <1% 530 $603.73
87641 <1% 26 $587.06
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 248 $568.91
90837 Psychotherapy session, about an hour <1% 16 $550.00
82728 <1% 257 $482.44
85651 <1% 884 $441.64
J8501 Aprepitant, oral, 5 mg <1% 26 $438.42
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 82 $434.94
73560 <1% 12 $431.96
82607 <1% 504 $421.74
J1815 Injection, insulin, per 5 units <1% 300 $418.12
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 550 $416.45
A9585 Injection, gadobutrol, 0.1 ml <1% 343 $388.25
87070 <1% 168 $381.35
73502 <1% 15 $369.76
90686 <1% 70 $360.70
82565 <1% 67 $348.40
84145 <1% 17 $335.14
J7070 Infusion, d5w, 1000 cc <1% 21 $333.06
88342 <1% 28 $318.08
G0008 Administration of influenza virus vaccine <1% 293 $298.77
80329 <1% 14 $198.19
87899 <1% 14 $182.54
82570 <1% 877 $176.07
88304 <1% 12 $175.11
87205 <1% 121 $172.48
87430 <1% 58 $171.78
87077 <1% 84 $156.49
82043 <1% 663 $152.68
90682 <1% 168 $146.99
83550 <1% 263 $141.48
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 25 $121.57
83540 <1% 335 $117.52
J3360 Injection, diazepam, up to 5 mg <1% 26 $114.70
J2795 Injection, ropivacaine hydrochloride, 1 mg <1% 98 $110.63
99152 <1% 26 $106.11
J3480 Injection, potassium chloride, per 2 meq <1% 37 $97.59
84153 <1% 141 $87.14
J1596 Injection, glycopyrrolate, 0.1 mg <1% 39 $77.25
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 393 $72.35
85008 <1% 520 $64.00
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 150 $58.99
82553 <1% 27 $52.34
87500 <1% 13 $38.51
85014 <1% 88 $36.20
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 15 $35.10
85018 <1% 88 $31.90
J1630 Injection, haloperidol, up to 5 mg <1% 14 $30.15
J1171 Injection, hydromorphone, 0.1 mg <1% 13 $21.26
Q4051 Splint supplies, miscellaneous (includes thermoplastics, strapping, fasteners, padding and other supplies) <1% 13 $11.95
87015 <1% 12 $10.20
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 16 $8.45
84550 <1% 55 $6.27
P9604 Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge <1% 158 $1.00
87147 0% 12 $0.00
J1010 Injection, methylprednisolone acetate, 1 mg 0% 16 $0.00
90792 Psychiatric diagnostic evaluation with medical services 0% 13 $0.00
85007 0% 127 $0.00
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 30 $0.00
J0171 Injection, adrenalin, epinephrine, 0.1 mg 0% 19 $0.00
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 0% 26 $0.00
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 0% 32 $0.00
80164 0% 17 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialWHITE, HERBERT (CHIEF FINANCIAL OFFICER)